Phase 3 Breast Cancer Trial, Not Yet Recruiting
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
- Women who have had a mastectomy (full breast removal) for invasive breast cancer.
- People who have had breast reconstruction surgery after mastectomy, or who have had a tissue expander inserted.
- People whose cancer was classified as stage IIIA or lower after surgery (excluding certain tumour and lymph node classifications — confirm with trial site), and who need additional radiation therapy after surgery.
- People with a general health and activity level rated at 2 or below on a standard medical scale (confirm with trial site).
- People aged 19 years or older.
- People who have agreed to take part in the study.
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- People who already had breast implants before their breast cancer diagnosis, or who had already completed reconstructive surgery before joining the trial.
- People who had reconstruction surgery after a partial breast removal rather than a full mastectomy.
- People who are currently using or planning to use an air-filled tissue expander.
- People receiving radiation therapy for the purpose of trying to cure a recurrence or to manage symptoms of advanced cancer.
- People who had cancer that had spread to other parts of the body at the time of their original diagnosis.
- People who are due to receive chemotherapy and radiation therapy at the same time.
- People who have cancer in both breasts.
- Male breast cancer patients.
- People who have previously received radiation therapy to the same breast or to the area above the collarbone on the same side.
- People with a history of cancers other than thyroid cancer, a pre-invasive cervical condition, or skin cancer.
- People whose breast cancer was identified as a specific non-invasive or less common tumour type, including ductal carcinoma in situ, lobular carcinoma in situ, phyllodes tumour, metaplastic cancer, or a benign tumour.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: In Ah Kim, MD. PhD., Seoul National University Bundang Hospital
Phone: 31-787-7651
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Primary endpoints
Major Complication Rate; Capsular Contracture (If implant-based recontruction is performed)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 8 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.